Chewy Inc (CHWY) Stock Price Today
Aura AI Summary
Key Stats
- $7.32BMarket Cap
- 8,073,550Volume
- Consumer CyclicalSector
- $39.1252W High
- $17.5152W Low
- 67 DaysTypical Hold Time
- $7.83BEnterprise Value
- -Div Yield
- -Trading Activity
Track Chewy Inc (CHWY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Chewy Inc has traded between a low of $17.51 and a high of $39.12, highlighting its annual price range. Buy and sell Chewy Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Chewy Inc
Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Most Recent News
Option Care Health deal price under investigation for fairness to shareholders.
Ademi LLP is investigating the proposed $5.8 billion acquisition of Option Care Health, where shareholders will receive $32.05 per share. The investigation focuses on whether the deal price fairly values the company, the benefits to insiders, restric...

Five stocks jump 21%-53% on news of acquisitions, blockchain, AI, and federal financing.
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...

Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.